… All these patients were confirmed and staged by cytomorphology, cell histochemistry,
cytogenetics and molecular genetics, and underwent alloHSCT in Nanfang Hospital within one …

… myeloid leukemia, myeloproliferative disorder, and myelodysplastic syndrome, or in the acute
phase of chronic myeloid leukemia, or … , cytogenetic and molecular genetic analyses. After …

… morphology, immunology, cytogenetic and molecular biology (MICM) in patients with chronic
myeloid leukemia in blastic crisis (… Cytogenetic and molecular genetic evolution of chronic …

Alkaloid from Cephalotaxus harringtonia; FDA approved orphan drug status for Ceflatonin in
the treatment of chronic myeloid leukemia due to being an inducer of apoptosis in myeloid …

… cytogenetic and molecular genetic characteristics. Among the most prevalent genetic mutations
in MDS,the TP53 gene … factor for the progression to acute myeloid leukemia(AML). The …

… Abstract: Chronic myeloid leukemia is a clonal myeloproliferative disease of hematopoietic
… leukemia and in 2 percent of patients with newly diagnosed acute myeloblastic leukemia. …

… investigate the clinical characteristics of patients with chronic myeloid leukemia (CML) in …
Molecular cytogenetic study of derivative chromosome 9 deletion in chronic myeloid leukemia …

… (24,25) Age, PS, HCT-CI, and cytogenetics are important prognostic factors for outcome …
myeloid leukemia for approximately 50 year-old , as well as those with chronic myeloid leukemia …

… ) and CYP3A5(rs776746) gene polymorphism with therapeutic efficacy of imatinib for chronic
myeloid leukemia (CML). … netic factors on the complete cytogenetic response at 1 year in …

… features and prognosis of patients with chronic myelogenous leukemia … primary chronic
myeloid leukemia (CML)-chronic phase … , complete cytogenetic response, major molecular …